Lanso Tad

Lansoprazole, the active ingredient in Lanso Tad, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat gastro‑esophageal reflux disease, peptic ulcer disease, Helicobacter pylori infection and erosive esophagitis in adults. GNH USA supplies Lanso Tad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole, a proton pump inhibitor, reduces gastric acid production and is used in several acid‑related gastrointestinal conditions.

- Gastroesophageal reflux disease (GERD): alleviates heartburn and regurgitation by decreasing acid exposure. - Peptic ulcer disease: promotes ulcer healing by suppressing gastric acid secretion. - Helicobacter pylori eradication: enhances antibiotic efficacy as part of combination therapy. - Erosive esophagitis: heals esophageal mucosal damage by limiting acid reflux.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools, usually self‑limiting. - Nausea: feeling of unease or upset stomach. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome): require immediate medical attention. - Clostridioides difficile infection: persistent diarrhea with possible colitis. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias. - Elevated liver enzymes: possible hepatic injury. - Interstitial nephritis: inflammation of kidney tissue. - Increased risk of bone fractures: especially with long‑term use.

Before initiating therapy with Lansoprazole, consider the following precautions.

- Renal function assessment: adjust use in patients with severe renal impairment. - Magnesium monitoring: check serum magnesium during prolonged treatment. - CYP2C19 metabolism: genetic variations may affect drug levels. - Elderly patients: use the lowest effective dose and monitor for fractures. - Discontinuation: avoid abrupt stopping after long‑term use to prevent rebound acid hypersecretion. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lansoprazole may interact with several medications; awareness of the interaction level is essential.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, leading to subtherapeutic antiviral levels. - Methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Digoxin: higher serum concentrations may occur; monitor levels. - Phenytoin: decreased phenytoin levels; adjust dosage as needed.